Showing results (51-60 of 73) with videos related to
Sort By:
Pageof 8
American Journal of Clinical Oncology|March 10, 2001
Prediction of node-negative breast cancer outcome by histologic grading and S-phase analysis by flow cytometry: an Eastern Cooperative Oncology Group Study (2192)D L Page, R Gray, D C Allred, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 30, 2016
Patient perspectives on the barriers associated with medication adherence to oral chemotherapyBenyam Muluneh, Allison Deal, Maurice D Alexander, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 14, 2012
IRB perspectives on the return of individual results from genomic researchLynn G Dressler, Sondra Smolek, Roselle Ponsaran, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2010
Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer StudyKatie M O'Brien, Stephen R Cole, Chiu-Kit Tse, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2000
Prognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer: results from the Eastern Cooperative Oncology Group Companion Study, EST 4189J F Simpson, R Gray, L G Dressler, et al.Journal of the National Cancer Institute. Monographs|January 1, 1992
Prognostic potential of DNA flow cytometry measurements in node-negative breast cancer patients: preliminary analysis of an intergroup study (INT 0076)L G Dressler, L Eudey, R Gray, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1992
Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patientsG M Clark, M C Mathieu, M A Owens, et al.Genome Research|June 3, 2011
Ethical and practical challenges of sharing data from genome-wide association studies: the eMERGE Consortium experienceAmy L McGuire, Melissa Basford, Lynn G Dressler, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 9, 2008
Influence of activation state of ErbB-2 (HER-2) on response to adjuvant cyclophosphamide, doxorubicin, and fluorouracil for stage II, node-positive breast cancer: study 8541 from the Cancer and Leukemia Group BMichael P DiGiovanna, David F Stern, Susan Edgerton, et al.Oncogene|September 14, 2004
Mutation of GATA3 in human breast tumorsJerry Usary, Victor Llaca, Gamze Karaca, et al.Pageof 8